Literature DB >> 12845485

Iterative reconstruction with correction of the spatially variant fan-beam collimator response in neurotransmission SPET imaging.

Deborah Pareto1, Albert Cot, Javier Pavía, Carles Falcón, Ignacio Juvells, Francisco Lomeña, Domènec Ros.   

Abstract

The dopamine transporter (DAT) has been shown to be a sensitive indicator of nigrostriatal dopamine function. Although visual inspection is often sufficient to assess DAT imaging, quantification could improve the diagnostic accuracy of single-photon emission tomography (SPET) studies of the dopaminergic system. The aim of this study was to assess the accuracy of quantification of the striatal/background uptake ratio when correction for attenuation, scatter and spatially variant fan-beam collimator response is performed in technetium-99m and iodine-123 SPET imaging. A numerical striatal phantom was implemented, and simulated projections of low-energy photons were obtained by using the SimSET Monte Carlo code. High-energy contamination in 123I studies was modelled from experimental measurements with 99mTc and 123I. The ordered subsets expectation maximisation (OSEM) algorithm was employed in reconstruction. Mean improvements of 8% and 16% were obtained in the calculated striatal/background uptake ratio in the putamen and the caudate, respectively, when the spatially variant point spread function was included in the transition matrix. Ideal scatter correction resulted in improvements in the putamen and caudate of 9% for 99mTc agents and 19% for 123I agents. Improvements averaged 31% in the putamen and 43% in the caudate when correction for attenuation, scatter and spatially variant collimator response was included in the reconstruction.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12845485     DOI: 10.1007/s00259-003-1229-7

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  19 in total

Review 1.  Probing targets for antipsychotic drug action with PET and SPET receptor imaging.

Authors:  L S Pilowsky
Journal:  Nucl Med Commun       Date:  2001-07       Impact factor: 1.690

2.  Can SPET imaging of dopamine uptake sites replace PET imaging in Parkinson's disease? For.

Authors:  Klaus Tatsch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-03-23       Impact factor: 9.236

3.  Accelerated image reconstruction using ordered subsets of projection data.

Authors:  H M Hudson; R S Larkin
Journal:  IEEE Trans Med Imaging       Date:  1994       Impact factor: 10.048

4.  [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease.

Authors:  J Booij; G Tissingh; G J Boer; J D Speelman; J C Stoof; A G Janssen; E C Wolters; E A van Royen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-02       Impact factor: 10.154

Review 5.  Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism.

Authors:  J Booij; G Tissingh; A Winogrodzka; E A van Royen
Journal:  Eur J Nucl Med       Date:  1999-02

6.  Comparative assessment of nine scatter correction methods based on spectral analysis using Monte Carlo simulations.

Authors:  I Buvat; M Rodriguez-Villafuerte; A Todd-Pokropek; H Benali; R Di Paola
Journal:  J Nucl Med       Date:  1995-08       Impact factor: 10.057

Review 7.  Leads for the development of neuroprotective treatment in Parkinson's disease and brain imaging methods for estimating treatment efficacy.

Authors:  J C Stoof; A Winogrodzka; F L van Muiswinkel; E C Wolters; P Voorn; H J Groenewegen; J Booij; B Drukarch
Journal:  Eur J Pharmacol       Date:  1999-06-30       Impact factor: 4.432

8.  Absolute activity quantitation in simultaneous 123I/99mTc brain SPECT.

Authors:  G El Fakhri; S C Moore; P Maksud; A Aurengo; M F Kijewski
Journal:  J Nucl Med       Date:  2001-02       Impact factor: 10.057

9.  [99mTc]TRODAT-1: a novel technetium-99m complex as a dopamine transporter imaging agent.

Authors:  M P Kung; D A Stevenson; K Plössl; S K Meegalla; A Beckwith; W D Essman; M Mu; I Lucki; H F Kung
Journal:  Eur J Nucl Med       Date:  1997-04

Review 10.  Development of technetium-99m-based CNS receptor ligands: have there been any advances?

Authors:  Bernd Johannsen; Hans-Jürgen Pietzsch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-02       Impact factor: 9.236

View more
  7 in total

1.  Iterative reconstruction or filtered backprojection for semi-quantitative assessment of dopamine D₂ receptor SPECT studies?

Authors:  Walter Koch; Christine Suessmair; Klaus Tatsch; Gabriele Pöpperl
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-02-02       Impact factor: 9.236

2.  The impact of reconstruction method on the quantification of DaTSCAN images.

Authors:  John C Dickson; Livia Tossici-Bolt; Terez Sera; Kjell Erlandsson; Andrea Varrone; Klaus Tatsch; Brian F Hutton
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-01       Impact factor: 9.236

3.  Quantification of dopaminergic neurotransmission SPECT studies with 123I-labelled radioligands. A comparison between different imaging systems and data acquisition protocols using Monte Carlo simulation.

Authors:  Cristina Crespo; Judith Gallego; Albert Cot; Carles Falcón; Santiago Bullich; Deborah Pareto; Pablo Aguiar; Josep Sempau; Francisco Lomeña; Francisco Calviño; Javier Pavía; Domènec Ros
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-03-12       Impact factor: 9.236

4.  Evaluation of a variable-aperture full-ring SPECT system using large-area pixelated CZT modules: A simulation study for brain SPECT applications.

Authors:  Yoonsuk Huh; Jaewon Yang; Odera U Dim; Yonggang Cui; Weijie Tao; Qiu Huang; Grant T Gullberg; Youngho Seo
Journal:  Med Phys       Date:  2021-03-30       Impact factor: 4.071

5.  The Role of CT-Based Attenuation Correction and Collimator Blurring Correction in Striatal Spect Quantification.

Authors:  J M Warwick; S Rubow; M du Toit; E Beetge; P Carey; P Dupont
Journal:  Int J Mol Imaging       Date:  2011-04-06

6.  Evaluation of Iterative Reconstruction Method and Attenuation Correction in Brain Dopamine Transporter SPECT Using an Anthropomorphic Striatal Phantom.

Authors:  Akira Maebatake; Ayaka Imamura; Yui Kodera; Yasuo Yamashita; Kazuhiko Himuro; Shingo Baba; Kenta Miwa; Masayuki Sasaki
Journal:  Asia Ocean J Nucl Med Biol       Date:  2016

7.  Attenuation and scatter correction in I-123 FP-CIT SPECT do not affect the clinical diagnosis of dopaminergic system neurodegeneration.

Authors:  Miho Akahoshi; Koichiro Abe; Yumiko Uchiyama; Mitsuru Momose; Kenji Fukushima; Kazuo Kitagawa; Shuji Sakai
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.